Tyme, Inc. (TYME)

Oncology Corporate Profile

Stock Performance

2.3400
0.0300

3 Month Stock History Chart

Data provided for free by IEX.

HQ Location

44 Wall Street, 12th Floor
New York, NY 10005

Company Description

Tyme, Inc. is a clinical-stage pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications.

Website: https://www.tymeinc.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
SM-88immunotherapyPancreatic CancerII
SM-88immunotherapyProstate cancerII

View additional information on product candidates here »

Source: https://www.tymeinc.com/

Recent News Headlines

There are no news items to display